SCHEMBL6594476

SCHEMBL6594476

N#Cc1ccc2c(c1)C(c1ncnc3cc(OCCOCCN4CCOCC4)ccc13)C(=O)N2

nearest known ligand 0.79

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 4/20 0.79
ALK Q9UM73 2/20 0.46
IRAK4 Q9NWZ3 2/20 0.44
HRH2 P25021 1/20 0.42
HRH1 P35367 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
TSHR P16473 1/20 0.41
ILK Q13418 1/20 0.41
KDM4E B2RXH2 1/20 0.40
RAF1 P04049 1/20 0.39
MAP2K1 Q02750 1/20 0.39
AURKA O14965 2/20 0.38
AURKB Q96GD4 2/20 0.38
PDGFRB P09619 2/20 0.38
MAPK8 P45983 1/20 0.38
CAMKK2 Q96RR4 1/20 0.38
ESR1 P03372 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4503506 0.99 CHEK1 (0.78) CHEK1ALKIRAK4HRH2HRH1
SCHEMBL3940162 0.95 CHEK1 (0.81) CHEK1ALKIRAK4HRH2HRH1
SCHEMBL3939280 0.95 CHEK1 (0.88) CHEK1ALKHRH2HRH1HRH3
SCHEMBL7211233 0.88 CHEK1 (1.00) CHEK1ALKHRH2HRH1HRH3
Hydrochloric Acid SCHEMBL4497841 0.86 CHEK1 (0.74) CHEK1IRAK4HRH2HRH1HRH3
Hydrochloric Acid SCHEMBL4495599 0.86 CHEK1 (0.74) CHEK1IRAK4HRH2HRH1HRH3
SCHEMBL3935762 0.85 CHEK1 (0.58) CHEK1ALKIRAK4ILKMAP2K1
Hydrochloric Acid SCHEMBL4505074 0.83 CHEK1 (0.63) CHEK1ALKIRAK4PDGFRB
SCHEMBL7205566 0.82 CHEK1 (0.68) CHEK1MAP2K1PDGFRB
SCHEMBL3942219 0.82 CHEK1 (0.60) CHEK1ALKIRAK4ILKMAP2K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458394-A1 USE OF OXINDOLE DERIVATIVES IN THE TREATMENT OF DEMENTIA RELATED DISEASES, ALZHEIMER S DISEASE AND CONDITIONS ASSOCIATED WITH GLYCOGEN SYNTHASE KINASE-3 AstraZeneca AB (SE) 2004-09-22 EP disclosed
WO-2003055492-A1 USE OF OXINDOLE DERIVATIVES IN THE TREATMENT OF DEMENTIA RELATED DISEASES, ALZHEIMER'S DISEASE AND CONDITIONS ASSOCIATED WITH GLYCOGEN SYNTHASE KINASE-3 ASTRAZENECA AB (SE) 2003-07-10 WO disclosed